Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: A phase I study

Seminars in Oncology

Volumn 24, Issue 6 SUPPL. 19, 1997, Pages

  Rosenthal, D I ^a   Sinard, R J ^a   Okani, O ^a   Corak, J ^a   Kavanaugh, D ^a   Kamen, B ^a   Vuitch, F M ^a   Gazdar, A F ^a   Griener, J ^a   Frenkel, E P ^a   Carbone, D P ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; PACLITAXEL; SODIUM CHLORIDE;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LYMPHOCYTOPENIA; MALE; MEGAVOLTAGE RADIOTHERAPY; MITOSIS INHIBITION; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBINOMETRY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PACLITAXEL;

EID: 17144452716     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)